Viridian Therapeutics, Inc.\DE (VRDN) Total liabilities 2016–2025
Viridian Therapeutics, Inc.\DE (VRDN) total liabilities at each fiscal year-end, per SEC filings.
$177.3MFY2025 · since FY2016: $9.7M → $177.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $177.3M | +150.5% |
| FY2024 | $70.8M | +46.2% |
| FY2023 | $48.4M | +20.9% |
| FY2022 | $40.0M | +150.3% |
| FY2021 | $16.0M | +42.6% |
| FY2020 | $11.2M | -22.7% |
| FY2019 | $14.5M | -2.0% |
| FY2018 | $14.8M | +6.0% |
| FY2017 | $14.0M | +44.0% |
| FY2016 | $9.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice